Sunday, Jun 13, 2021
Focus on the big picture

FDA Gives Green Light to Biogen's Alzheimer’s Drug

Bloomberg, 07 Jun 2021
Jun.07 -- The FDA approved Biogen's controversial Alzheimer's disease therapy, which will be sold under the name Aduhelm. The drug works by removing ...
Related Articles